Epidemiology and Demographics of the Head and Neck Cancer Population

Oral and Maxillofacial Surgery Clinics of North America

Volumn 30, Issue 4, 2018, Pages 381-395

  Cohen, Natasha ^a   Fedewa, Stacey ^b   Chen, Amy Y ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

Cancer; Epidemiology; Head and neck; HPV; Risk factors

Indexed keywords

CANCER REGISTRY; CANCER STAGING; DEMOGRAPHY; FEMALE; HEAD AND NECK TUMOR; HUMAN; INCIDENCE; MALE; PATHOLOGY; PROGNOSIS; RISK FACTOR; UNITED STATES;

DEMOGRAPHY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 85050868495     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2018.06.001     Document Type: Review

References (145)

1. Gillison, M.L., Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health 43:4 Suppl (2008), S52–S60.
2. Lydiatt, W.M., Patel, S.G., O'Sullivan, B., et al. Head and neck cancers-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67:2 (2017), 122–137.
3. Winn, D.M., Lee, Y.C., Hashibe, M., et al., INHANCE Consortium. The INHANCE consortium: toward a better understanding of the causes and mechanisms of head and neck cancer. Oral Dis 21:6 (2015), 685–693.
4. SEER cancer stat facts: oral cavity and pharynx cancer. Available at: https://seer.cancer.gov/statfacts/html/oralcav.html. Accessed December 17, 2017.
5. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2017. CA Cancer J Clin 67:1 (2017), 7–30.
6. Howlader N, NA, Krapcho M, et al, editors. SEER cancer statistics review, 1975-2014. April 2017; based on November 2016 SEER data submission, posted to the SEER web site. 2017. Available at: https://seer.cancer.gov/csr/1975_2014/. Accessed December 18, 2017.
7. SEER cancer stat facts: laryngeal cancer. Available at: http://seer.cancer.gov/statfacts/html/laryn.html. Accessed December 17, 2017.
8. Hashibe, M., Brennan, P., Benhamou, S., et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:10 (2007), 777–789.
9. Freedman, N.D., Schatzkin, A., Leitzmann, M.F., et al. Alcohol and head and neck cancer risk in a prospective study. Br J Cancer 96:9 (2007), 1469–1474.
10. Altieri, A., Garavello, W., Bosetti, C., et al. Alcohol consumption and risk of laryngeal cancer. Oral Oncol 41:10 (2005), 956–965.
11. Talamini, R., Bosetti, C., La Vecchia, C., et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 13:10 (2002), 957–964.
12. Guzzo, M., Locati, L.D., Prott, F.J., et al. Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:2 (2010), 134–148.
13. Thom, J.J., Moore, E.J., Price, D.L., et al. The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma. JAMA Otolaryngol Head Neck Surg 140:6 (2014), 548–554.
14. Spiro, R.H., Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8:3 (1986), 177–184.
15. Boukheris, H., Curtis, R.E., Land, C.E., et al. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev 18:11 (2009), 2899–2906.
16. Yoo, G.H., Eisele, D.W., Askin, F.B., et al. Warthin's tumor: a 40-year experience at The Johns Hopkins Hospital. Laryngoscope 104:7 (1994), 799–803.
17. Land, C.E., Saku, T., Hayashi, Y., et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat Res 146:1 (1996), 28–36.
18. Belsky, J.L., Tachikawa, K., Cihak, R.W., et al. Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970. JAMA 219:7 (1972), 864–868.
19. Preston-Martin, S., Thomas, D.C., White, S.C., et al. Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J Natl Cancer Inst 80:12 (1988), 943–949.
20. Preston-Martin, S., White, S.C., Brain and salivary gland tumors related to prior dental radiography: implications for current practice. J Am Dent Assoc 120:2 (1990), 151–158.
21. Modan, B., Chetrit, A., Alfandary, E., et al. Increased risk of salivary gland tumors after low-dose irradiation. Laryngoscope 108:7 (1998), 1095–1097.
22. Hoffman, D.A., McConahey, W.M., Fraumeni, J.F. Jr., et al. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 11:3 (1982), 218–224.
23. Saluja, K., Butler, R.T., Pytynia, K.B., et al. Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association. Hum Pathol 68 (2017), 189–192.
24. Horn-Ross, P.L., Morrow, M., Ljung, B.M., Menstrual and reproductive factors for salivary gland cancer risk in women. Epidemiology 10:5 (1999), 528–530.
25. Zheng, W., Shu, X.O., Ji, B.T., et al. Diet and other risk factors for cancer of the salivary glands: a population-based case-control study. Int J Cancer 67:2 (1996), 194–198.
26. Dietz, A., Barme, B., Gewelke, U., et al. The epidemiology of parotid tumors. A case control study. HNO 41:2 (1993), 83–90 [in German].
27. Turner, J.H., Reh, D.D., Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 34:6 (2012), 877–885.
28. Waldron, J., Witterick, I., Paranasal sinus cancer: caveats and controversies. World J Surg 27:7 (2003), 849–855.
29. Voss, R., Stenersen, T., Roald Oppedal, B., et al. Sinonasal cancer and exposure to softwood. Acta Otolaryngol 99:1–2 (1985), 172–178.
30. Innos, K., Rahu, M., Rahu, K., et al. Wood dust exposure and cancer incidence: a retrospective cohort study of furniture workers in Estonia. Am J Ind Med 37:5 (2000), 501–511.
31. Gordon, I., Boffetta, P., Demers, P.A., A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers. Epidemiology 9:5 (1998), 518–524.
32. Partanen, T., Formaldehyde exposure and respiratory cancer: a meta-analysis of the epidemiologic evidence. Scand J Work Environ Health 19:1 (1993), 8–15.
33. Luce, D., Leclerc, A., Begin, D., et al. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control 13:2 (2002), 147–157.
34. Olsen, J.H., Occupational risks of sinonasal cancer in Denmark. Br J Ind Med 45:5 (1988), 329–335.
35. Selden, A.I., Westberg, H.B., Axelson, O., Cancer morbidity in workers at aluminum foundries and secondary aluminum smelters. Am J Ind Med 32:5 (1997), 467–477.
36. Karjalainen, S., Kerttula, R., Pukkala, E., Cancer risk among workers at a copper/nickel smelter and nickel refinery in Finland. Int Arch Occup Environ Health 63:8 (1992), 547–551.
37. Slack, R., Young, C., Rushton, L., British Occupational Cancer Burden Study Group. Occupational cancer in Britain. Nasopharynx and sinonasal cancers. Br J Cancer 107:Suppl 1 (2012), S49–S55.
38. ’t Mannetje, A., Kogevinas, M., Luce, D., et al. Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med 36:1 (1999), 101–107.
39. Hayes, R.B., Kardaun, J.W., de Bruyn, A., Tobacco use and sinonasal cancer: a case-control study. Br J Cancer 56:6 (1987), 843–846.
40. Thavaraj, S., Human papillomavirus-associated neoplasms of the sinonasal tract and nasopharynx. Semin Diagn Pathol 33:2 (2016), 104–111.
41. Yu, H.X., Liu, G., Malignant transformation of sinonasal inverted papilloma: a retrospective analysis of 32 cases. Oncol Lett 8:6 (2014), 2637–2641.
42. Syrjanen, K., Syrjanen, S., Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis. Laryngoscope 123:1 (2013), 181–192.
43. World Health Organization. WHO report on the global tobacco epidemic, 2013. 2013. Available at: http://apps.who.int/iris/bitstream/10665/85380/1/9789241505871_eng.pdf?ua=1. Accessed December 24, 2017.
44. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 83 (2004), 1–1438.
45. Office of the Surgeon General (US), Office on Smoking and Health (US). The health consequences of smoking: a report of the surgeon general. 2004, The Centers for Disease Control and Prevention (US), Atlanta (GA).
46. World Health Organization, International Agency for Research on Cancer. [press release] IARC strengthens its findings on several carcinogenic personal habits and household exposures, 2009, WHO, Lyons (France).
47. Preamble to the IARC monographs. 2006. Available at: http://monographs.iarc.fr/ENG/Preamble/currentb6evalrationale0706.php. Accessed December 24, 2017.
48. International Agency for Research on Cancer. World cancer report, 2014, IARC, Lyons (France).
49. Oreggia, F., De Stefani, E., Correa, P., et al. Risk factors for cancer of the tongue in Uruguay. Cancer 67:1 (1991), 180–183.
50. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Diesel and gasoline engine exhausts and some nitroarenes. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum 105 (2014), 9–699.
51. De Stefani, E., Boffetta, P., Oreggia, F., et al. Smoking patterns and cancer of the oral cavity and pharynx: a case-control study in Uruguay. Oral Oncol 34:5 (1998), 340–346.
52. Franceschi, S., Barra, S., La Vecchia, C., et al. Risk factors for cancer of the tongue and the mouth. A case-control study from northern Italy. Cancer 70:9 (1992), 2227–2233.
53. Berthiller, J., Straif, K., Agudo, A., et al. Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis. Int J Epidemiol 45:3 (2016), 835–845.
54. Wyss, A., Hashibe, M., Chuang, S.C., et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol 178:5 (2013), 679–690.
55. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 89 (2007), 1–592.
56. Phillips, E., Wang, T.W., Husten, C.G., et al. Tobacco product use among adults: United States, 2015. MMWR Morb Mortal Wkly Rep 66:44 (2017), 1209–1215.
57. Adriaens, K., Van Gucht, D., Declerck, P., et al. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health 11:11 (2014), 11220–11248.
58. Hatsukami, D.K., Lemmonds, C., Tomar, S.L., Smokeless tobacco use: harm reduction or induction approach?. Prev Med 38:3 (2004), 309–317.
59. Stratton K, Shetty P, Wallace R, et al, editors. Clearing the smoke: assessing the science base for tobacco harm reduction. The National Academies Press: Washington, DC; 2001.
60. Cullen, J.W., Blot, W., Henningfield, J., et al. Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General. Public Health Rep 101:4 (1986), 355–373.
61. Hecht, S.S., Rivenson, A., Braley, J., et al. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res 46:8 (1986), 4162–4166.
62. Rodu, B., Cole, P., Smokeless tobacco use and cancer of the upper respiratory tract. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:5 (2002), 511–515.
63. Barraza, L.F., Weidenaar, K.E., Cook, L.T., et al. Regulations and policies regarding e-cigarettes. Cancer 123:16 (2017), 3007–3014.
64. Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS). Available at: https://www.fda.gov/TobaccoProducts/Labeling/ProductsIngredientsComponents/ucm456610.htm. Accessed January 15, 2018.
65. Schoenborn, C.A., Gindi, R.M., Electronic cigarette use among adults. 2015, National Center for Health Statistics, Hyattsville (MD).
66. Miech, R.A., Johnston, L.D., O'Malley, P.M., et al. Monitoring the future national survey results on drug use, 1975-2016. 2017, Institute for Social Research, The University of Michigan, Ann Arbor (MI).
67. Pepper, J.K., Emery, S.L., Ribisl, K.M., et al. How risky is it to use e-cigarettes? Smokers’ beliefs about their health risks from using novel and traditional tobacco products. J Behav Med 38:2 (2015), 318–326.
68. Franks, A.M., Hawes, W.A., McCain, K.R., et al. Electronic cigarette use, knowledge, and perceptions among health professional students. Curr Pharm Teach Learn 9:6 (2017), 1003–1009.
69. Jamal, A., Gentzke, A., Hu, S.S., et al. Tobacco use among middle and high school students—United States, 2011-2016. MMWR Morb Mortal Wkly Rep 66:23 (2017), 597–603.
70. Yu, V., Rahimy, M., Korrapati, A., et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol 52 (2016), 58–65.
71. Holliday, R., Kist, R., Bauld, L., E-cigarette vapour is not inert and exposure can lead to cell damage. Evid Based Dent 17:1 (2016), 2–3.
72. Summary of Federal Rules for Tobacco Retailers. Available at: https://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/Retail/ucm205021.htm - ecig. Accessed December 24, 2017.
73. Hartmann-Boyce, J., McRobbie, H., Bullen, C., et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev(9), 2016 CD010216.
74. Bullen, C., Howe, C., Laugesen, M., et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382:9905 (2013), 1629–1637.
75. Caponnetto, P., Campagna, D., Cibella, F., et al. EffiCiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One, 8(6), 2013, e66317.
76. Primack, B.A., Shensa, A., Sidani, J.E., et al. Initiation of traditional cigarette smoking after electronic cigarette use among tobacco-naïve U.S. young adults. Am J Med, 131(4), 2018, 443.e1-9.
77. Schrot, R.J., Hubbard, J.R., Cannabinoids: medical implications. Ann Med 48:3 (2016), 128–141.
78. NIDA. Marijuana. National Institute on Drug Abuse website. Available at: https://www.drugabuse.gov/drugs-abuse/marijuana. Accessed December 24, 2017.
79. Aldington, S., Harwood, M., Cox, B., et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 31:2 (2008), 280–286.
80. Polen, M.R., Sidney, S., Tekawa, I.S., et al. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 158:6 (1993), 596–601.
81. Busch, F.W., Seid, D.A., Wei, E.T., Mutagenic activity of marihuana smoke condensates. Cancer Lett 6:6 (1979), 319–324.
82. Zhang, Z.F., Morgenstern, H., Spitz, M.R., et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 8:12 (1999), 1071–1078.
83. Rosenblatt, K.A., Daling, J.R., Chen, C., et al. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res 64:11 (2004), 4049–4054.
84. Llewellyn, C.D., Linklater, K., Bell, J., et al. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 40:3 (2004), 304–313.
85. Hashibe, M., Morgenstern, H., Cui, Y., et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 15:10 (2006), 1829–1834.
86. Aldington, S., Harwood, M., Cox, B., et al. Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg 138:3 (2008), 374–380.
87. Llewellyn, C.D., Johnson, N.W., Warnakulasuriya, K.A., Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med 33:9 (2004), 525–532.
88. Gillison, M.L., D'Souza, G., Westra, W., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:6 (2008), 407–420.
89. Committee on Substance Abuse, Committee on Adolescence, Committee on Substance Abuse Committee on Adolescence. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics 135:3 (2015), 584–587.
90. Monte, A.A., Zane, R.D., Heard, K.J., The implications of marijuana legalization in Colorado. JAMA 313:3 (2015), 241–242.
91. D'Souza, D.C., Ranganathan, M., Medical marijuana: is the cart before the horse?. JAMA 313:24 (2015), 2431–2432.
92. Hall, W., Degenhardt, L., Adverse health effects of non-medical cannabis use. Lancet 374:9698 (2009), 1383–1391.
93. Goldstein, B.Y., Chang, S.C., Hashibe, M., et al. Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update. Eur J Cancer Prev 19:6 (2010), 431–465.
94. Boeing, H., EPIC Working Group on Dietary Patterns. Alcohol and risk of cancer of the upper gastrointestinal tract: first analysis of the EPIC data. IARC Sci Publ 156 (2002), 151–154.
95. Alcohol drinking. IARC Working Group, Lyon, 13-20 October 1987. IARC Monogr Eval Carcinog Risks Hum 44 (1988), 1–378.
96. Koch, W.M., McQuone, S., Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker. Curr Opin Oncol 9:3 (1997), 257–261.
97. Blot, W.J., McLaughlin, J.K., Winn, D.M., et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:11 (1988), 3282–3287.
98. Schatzkin, A., Subar, A.F., Thompson, F.E., et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154:12 (2001), 1119–1125.
99. Burd, E.M., Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1 (2003), 1–17.
100. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90 (2007), 1–636.
101. Satterwhite, C.L., Torrone, E., Meites, E., et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 40:3 (2013), 187–193.
102. de Sanjose, S., Diaz, M., Castellsague, X., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:7 (2007), 453–459.
103. Hinchliffe, S.A., van Velzen, D., Korporaal, H., et al. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer 72:4 (1995), 943–945.
104. Moscicki, A.B., Shiboski, S., Broering, J., et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 132:2 (1998), 277–284.
105. Flores, E.R., Allen-Hoffmann, B.L., Lee, D., et al. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology 262:2 (1999), 344–354.
106. Gao, G., Smith, D.I., Human papillomavirus and the development of different cancers. Cytogenet Genome Res 150:3–4 (2016), 185–193.
107. Munoz, N., Castellsague, X., de Gonzalez, A.B., et al. Chapter 1: HPV in the etiology of human cancer. Vaccine, 24(Suppl 3), 2006, S3/1-10.
108. Klussmann, J.P., Gultekin, E., Weissenborn, S.J., et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162:3 (2003), 747–753.
109. Gillison, M.L., Koch, W.M., Capone, R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:9 (2000), 709–720.
110. El-Mofty, S.K., Human papillomavirus-related head and neck squamous cell carcinoma variants. Semin Diagn Pathol 32:1 (2015), 23–31.
111. Dahlstrom, K.R., Adler-Storthz, K., Etzel, C.J., et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 9:7 (2003), 2620–2626.
112. Stevens, T.M., Bishop, J.A., HPV-related carcinomas of the head and neck: morphologic features, variants, and practical considerations for the surgical pathologist. Virchows Arch 471:2 (2017), 295–307.
113. Carpén, T., Sjöblom, A., Lundberg, M., et al. Presenting symptoms and clinical findings in HPV-positive and HPV-negative oropharyngeal cancer patients. Acta Otolaryngol 138:5 (2018), 513–518.
114. Westra, W.H., The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol 6:Suppl 1 (2012), S48–S54.
115. Jackson, R.S., Sinha, P., Zenga, J., et al. Transoral resection of human papillomavirus (HPV)-positive squamous cell carcinoma of the oropharynx: outcomes with and without adjuvant therapy. Ann Surg Oncol 24:12 (2017), 3494–3501.
116. D'Souza, G., Kreimer, A.R., Viscidi, R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:19 (2007), 1944–1956.
117. Schwartz, S.M., Daling, J.R., Doody, D.R., et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90:21 (1998), 1626–1636.
118. Herrero, R., Castellsague, X., Pawlita, M., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95:23 (2003), 1772–1783.
119. Smith, E.M., Ritchie, J.M., Summersgill, K.F., et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96:6 (2004), 449–455.
120. Chaturvedi, A.K., D'Souza, G., Gillison, M.L., et al. Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population. Oral Oncol 60 (2016), 61–67.
121. Shi, L.L., Bradford, E., Depalo, D.E., et al. Betel quid use and oral cancer in a high-risk refugee community in the USA: the effectiveness of an awareness initiative. J Cancer Educ, 2017 [Epub ahead of print].
122. Gupta, P.C., Ray, C.S., Epidemiology of betel quid usage. Ann Acad Med Singapore 33:4 Suppl (2004), 31–36.
123. Krais, S., Klima, M., Huppertz, L.M., et al. Betel nut chewing in Iron Age Vietnam? Detection of areca catechu alkaloids in dental enamel. J Psychoactive Drugs 49:1 (2017), 11–17.
124. Gupta, P.C., Warnakulasuriya, S., Global epidemiology of areca nut usage. Addict Biol 7:1 (2002), 77–83.
125. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 85 (2004), 1–334.
126. Reichart, P.A., Phillipsen, H.P., Betel chewer's mucosa: a review. J Oral Pathol Med 27:6 (1998), 239–242.
127. Reichart, P.A., Mohr, U., Srisuwan, S., et al. Precancerous and other oral mucosal lesions related to chewing, smoking and drinking habits in Thailand. Community Dent Oral Epidemiol 15:3 (1987), 152–160.
128. Saravanan, K., Kodanda Ram, M., Ganesh, R., Molecular biology of oral sub mucous fibrosis. J Cancer Res Ther 9:2 (2013), 179–180.
129. Franco, E.L., Kowalski, L.P., Oliveira, B.V., et al. Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer 43:6 (1989), 992–1000.
130. Marshall, J.R., Graham, S., Haughey, B.P., et al. Smoking, alcohol, dentition and diet in the epidemiology of oral cancer. Eur J Cancer B Oral Oncol 28B:1 (1992), 9–15.
131. Rosenquist, K., Wennerberg, J., Schildt, E.B., et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in Southern Sweden. Acta Otolaryngol 125:12 (2005), 1327–1336.
132. Lissowska, J., Pilarska, A., Pilarski, P., et al. Smoking, alcohol, diet, dentition and sexual practices in the epidemiology of oral cancer in Poland. Eur J Cancer Prev 12:1 (2003), 25–33.
133. Chang, J.S., Lo, H.I., Wong, T.Y., et al. Investigating the association between oral hygiene and head and neck cancer. Oral Oncol 49:10 (2013), 1010–1017.
134. Gogarty, D.S., Shuman, A., O'Sullivan, E.M., et al. Conceiving a national head and neck cancer screening programme. J Laryngol Otol 130:1 (2016), 8–14.
135. Mehanna, H., Paleri, V., West, C.M., et al. Head and neck cancer–Part 1: epidemiology, presentation, and prevention. BMJ, 341, 2010, c4684.
136. Marron, M., Boffetta, P., Zhang, Z.F., et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 39:1 (2010), 182–196.
137. Kreimer, A.R., Prospects for prevention of HPV-driven oropharynx cancer. Oral Oncol 50:6 (2014), 555–559.
138. Herrero, R., Quint, W., Hildesheim, A., et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One, 8(7), 2013, e68329.
139. Herrero, R., Hildesheim, A., Rodriguez, A.C., et al. Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine 26:37 (2008), 4795–4808.
140. Durzynska, J., Pacholska-Bogalska, J., Kaczmarek, M., et al. HPV genotypes in the oral cavity/oropharynx of children and adolescents: cross-sectional survey in Poland. Eur J Pediatr 170:6 (2011), 757–761.
141. Lenzi, A., Mirone, V., Gentile, V., et al. Rome Consensus Conference: statement; human papilloma virus diseases in males. BMC Public Health, 13, 2013, 117.
142. Clinician FAQs: CDC recommendations for HPV vaccine 2-dose schedule. Available at: https://www.cdc.gov/hpv/downloads/HCVG15-PTT-HPV-2Dose.pdf. Accessed December 25, 2017.
143. Markowitz, L.E., Hariri, S., Lin, C., et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 208:3 (2013), 385–393.
144. HPV vaccination coverage data. Available at: https://www.cdc.gov/hpv/hcp/vacc-coverage.html. Accessed December 25, 2017.
145. HPV vaccine information for clinicians. Available at: https://www.cdc.gov/hpv/hcp/need-to-know.pdf. Accessed December 25, 2017.